SCHEMBL13672046

SCHEMBL13672046

COC(=O)[C@H]1CC[C@H](N=[N+]=[N-])[C@@H](O)C1

nearest known ligand 0.40

Predicted protein targets (top 9)

geneUniProtsupporting neighboursconfidence
▸ MMP2 P08253 1/20 0.40
▸ ANPEP P15144 1/20 0.40
▸ CHRNB2 P17787 2/20 0.34
▸ CHRNA4 P43681 2/20 0.34
▸ CHRNB4 P30926 1/20 0.34
▸ CHRNA3 P32297 1/20 0.34
▸ CHRNA7 P36544 1/20 0.34
▸ TP53 P04637 1/20 0.32
▸ SMN1; SMN2 Q16637 1/20 0.30

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL25286492 1.00 MMP2 (0.40) MMP2ANPEPCHRNB2CHRNA4CHRNB4
SCHEMBL13672052 1.00 MMP2 (0.40) MMP2ANPEPCHRNB2CHRNA4CHRNB4
SCHEMBL22629334 1.00 MMP2 (0.40) MMP2ANPEPCHRNB2CHRNA4CHRNB4
SCHEMBL14403910 1.00 MMP2 (0.40) MMP2ANPEPCHRNB2CHRNA4CHRNB4
SCHEMBL14403914 0.88 MMP2 (0.40) MMP2ANPEPCHRNB2CHRNA4CHRNB4
SCHEMBL31664512 0.87 MMP2 (0.42) MMP2ANPEPCHRNB2CHRNA4CHRNB4
SCHEMBL27740704 0.87 MMP2 (0.42) MMP2ANPEPCHRNB2CHRNA4CHRNB4
SCHEMBL15796255 0.87 MMP2 (0.42) MMP2ANPEPCHRNB2CHRNA4CHRNB4
SCHEMBL13631040 0.82 MMP2 (0.31) MMP2ANPEP
SCHEMBL13696040 0.80 CHRNB2 (0.47) MMP2ANPEPCHRNB2CHRNA4CHRNB4

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 3 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
WO-2023122772-A1 OXIME DERIVATIVES USEFUL AS T CELL ACTIVATORS GOSSAMER BIO SERVICES, INC. (US) 2023-06-29 — — WO disclosed
US-7601714-B2 Pyrimidine derivatives useful as inhibitors of PKC-theta BOEHRINGER INGELHEIM PHARMACEUTICALS, INC. (US) 2009-10-13 — — US disclosed
US-7601714-B2 Pyrimidine derivatives useful as inhibitors of PKC-theta BOEHRINGER INGELHEIM PHARMACEUTICALS, INC. (US) 2009-10-13 — — US disclosed
Send feedback